DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for the Active Substance Aripiprazole (Excl. Dafo for the Production of a Depot Injection Suspension) F. D. Dates 02/01/2023 - 01/31/2025. The project location is Germany and the tender is closing on 05 Dec 2024. The tender notice number is -, while the TOT Ref Number is 76422235.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for the Active Substance Aripiprazole (Excl. Dafo for the Production of a Depot Injection Suspension) F. D. Dates 02/01/2023 - 01/31/2025
Sign in with Google